USC News looks back on the year in construction at USC, highlighting the USC Village and Michelson Hall, home of the USC Michelson Center for Convergent Bioscience, as two projects that “will leave lasting impacts on future generations of Trojans and scientific research.” (December 26, 2017)
USC Viterbi News writes about a new study out of the USC Viterbi School of Engineering that finds tumor growth properties can influence response to cancer drugs. “Identifying a measurement or quantity that predicts how specific tumors will respond, called a predictive biomarker, is extremely valuable to cancer research,” said Stacey Finley, a USC assistant professor of Biomedical Engineering, co-author to the study, the Gordon S. Marshall Early Career Chair, and a faculty member at the USC Michelson Center for Convergent Bioscience. (December 21, 2017)
USC News writes: “What if scientists could develop an opioid-based painkiller that is not addictive and has limited side effects? That is possible based on new findings by an international team of scientists that included contributions from top researchers at the USC Michelson Center for Convergent Bioscience … The findings were published Jan. 4 in the journal Cell. They are an example of how USC Michelson Center scientists collaborate with a range of experts in multiple disciplines to conduct groundbreaking research.” (January 4, 2018)
On Facebook Live, USC researchers Peter Kuhn, of the USC Michelson Center for Convergent Bioscience, and John Carpten, of Keck Medicine of USC’s Institute of Translational Genomics, discuss the connection between diversity and cancer research to enable personalized cancer treatment.
USC Viterbi writes that a team of USC researchers that developed a new material to self-regulate the temperature of a satellite, working in conjunction with a team at Northrop Grumman, will benefit from “the new capabilities in the recently-dedicated John D. O’Brien Nanofabrication Laboratory in the USC Michelson Center for Convergent Bioscience.”
The Viterbi Voices podcast featured Dr. Eun-Ji Chung, and talked to her about her research lab, which is involved in everything from “stem cell work, to nanomedicine, to highly specialized drug delivery techniques.”
The Viterbi Voices podcast featured Dr. Andrea Armani, and talked to her about her path to becoming a chemical engineering professor at USC, her interdisciplinary lab, and the USC Michelson Center for Convergent Bioscience. Dr. Armani’s lab will be moving to Michelson in December, and she will serve there as director of the cleanroom.
The USC Iovine and Young Academy announced a grant from the Phase ONE Foundation that will initiate a full-scale, four-year undergraduate track focused on health innovation to help patients achieve better outcomes, anticipated to launch in fall 2019. Since last year, students have been working with USC’s Convergent Science Initiative in Cancer led by Peter Kuhn, a faculty member at the USC Michelson Center for Convergent Bioscience and dean’s professor at the USC Dornsife College of Letters, Arts and Sciences, to “hack cancer,” as Kuhn puts it. (November 30, 2017)
On November 9, 2017, family, friends, faculty, and staff gathered to celebrate the naming of the John D. O’Brien Nanofabrication Lab dedicated to the beloved, former Executive Vice Dean of the USC Viterbi School of Engineering, who passed away unexpectedly last March. (November 13, 2017)
Forbes writes that “It’s hard to over-stress how big a breakthrough this USC IP course is. Until recently, intellectual property had been taught only in law schools or the occasional business school seminar.” The outlet notes that for Dr. Gary Michelson, the course “helps fulfil a promise he made to his crippled grandmother half a century ago to find cures for disease.” (November 9, 2017)